Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: A proton magnetic resonance spectroscopy study

NeuroImage

Volumn 47, Issue 1, 2009, Pages 36-41

  Milne, Andrea ^a   MacQueen, Glenda M ^a,c   Yucel, Kaan ^a   Soreni, Noam ^a   Hall, Geoffrey B C ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Brain Body Institute   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Choline; Hippocampus; Magnetic resonance spectroscopy; Major depressive disorder

Indexed keywords

CHOLINE DERIVATIVE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; METABOLIC ENCEPHALOPATHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; CHOLINE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLUTAMIC ACID; GLUTAMINE; HIPPOCAMPUS; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; ORGAN SIZE; PROTONS; RECURRENCE;

EID: 67349211315     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.03.031     Document Type: Article

References (47)

1. Ajilore O., Haroon E., Kumaran S., Darwin D., Binesh N., Mintz J., Miller J., Thomas M.A., and Kumar A. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology 32 6 (2007) 1224-1231
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (1994), Washington, D.C.
3. Beck A.T., and Beamesderfer A. Assessment of depression: the depression inventory. Mod. Probl. Pharmacopsychiatry 7 (1974) 151-169
4. Block W., Traber F., von Widdern O., Metten M., Schild H., Maier W., Zobel A., and essen F. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int. J. Neuropsychopharmacol. (2008) 1-8
5. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 157 1 (2000) 115-118
6. Brown S.E., Woolston D.J., Frol A., Bobadilla L., Khan D.A., Hanczyc M., Rush A.J., Fleckenstein J., Babcock E., and Cullum C.M. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry 55 (2004) 538-545
7. Burtscher I.M., and Holtas S. Proton MR spectroscopy in clinical routine. J. Magn. Reson. Imaging 13 4 (2001) 560-567
8. Caetano S.C., Fonseca M., Olvera R.L., Nicoletti M., Hatch J.P., Stanley J.A., Hunter K., Lafer B., Pliszka S.R., and Soares J.C. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci. Lett. 384 (2005) 321-326
9. Campbell S., Marriott M., Nahmias C., and MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 161 (2004) 598-607
10. Czeh B., and Lucassen P.J. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?. Eur. Arch. Psychiatry Clin. Neurosci. 257 5 (2007) 250-260
11. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., and Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 61 5 (2004) 450-458
12. Farchione T.R., Moore G.J., and Rosenberg D.R. Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biol. Psychiatry 15 2 (2002) 86-92
13. Finkelstein Y., Koffler B., Rabey J.M., and Gilad G.M. Dynamics of cholinergic synaptic mechanisms in rat hippocampus after stress. Brain Res. 343 2 (1985) 314-319
14. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV (SCID-I) (1998), Biomedics Research Department, New York
15. Gadian D.G. N-acetylaspartate and epilepsy. Magn. Reson. Imaging 13 8 (1995) 1193-1195
16. Gilad G.M., Mahon B.D., Finkelstein Y., Koffler B., and Gilad V.H. Stress-induced activation of the hippocampal cholinergic system and the pituitary-adrenocortical axis. Brain Res, 347 2 (1985) 404-408
17. Glitz D.A., Manji H.K., and Moore G. Mood disorders: treatment-induced changes in brain neurochemistry and structure. Semin. Clin. Neuropsychiatry 7 4 (2002) 269-280
18. Gonul A.S., Kitis O., Ozan E., Akdeniz F., Eker C., Eker O.D., et al. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 1 (2006) 120-125
19. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
20. Hortnagl H., Berger M.L., Havelec L., and Hornykiewicz O. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A). J. Neurosci. 13 7 (1993) 2939-2945
21. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., and Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur. J. Pharmacol. 165 2-3 (1989) 337-338
22. Kato T., Inubushi T., and Kato N. Magnetic resonance spectroscopy in affective disorders. J. Neuropsychiatry Clin. Neurosci. 10 2 (1998) 133-147
23. Klein J., Gonzalez R., Koppen A., and Loffelholz K. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem. Int. 22 (1993) 293-300
24. Kumar A., Thomas A., Lavretsky J., Yue K., huda A., Curran J., Venkatraman T., Estanol L., Mintz J., Mega M., and Toga A. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am. J. Psychiatry 159 (2002) 630-636
25. Loffelholz K. Receptor regulation of choline phospholipid hydrolysis. A novel source of diacylglylcerol and phosphatidic acid. Biochem. Pharmacol. 38 (1989) 1543-1549
26. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmais C., and Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression. PNAS 100 3 (2003) 1387-1392
27. Malhi G.S., Valenzuela M., Wen W., and Sachdev P. Magnetic resonance spectroscopy and its applications in psychiatry. Aust. N Z J Psychiatry 36 1 (2002) 31-43
28. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22 (1999) 105-122
29. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. N. Y. Acad. Sci. 933 (2001) 265-277
30. McEwen B.S. Mood disorders and allostatic load. Biological Psychiatry 54 3 (2003) 200-207
31. McKinnon M.C., Yucel K., Nazarov A., and MacQueen G.M. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J. Psychiatry Neurosci 34 1 (2009) 41-54
32. Mervaala E., Fohr J., Kononen M., Valkonen-Korhonen M., Vainio P., Partanen K., Tiihonen J., Viinamaki H., Karjalainen A.K., and Lehtonen J. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol. Med. 30 1 (2000) 117-125
33. Miller B.L., Chang L., Booth R., Ernst T., Cornford M., Nikas D., McBride D., and Jenden D.J. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci. 58 22 (1996) 1929-1935
34. Pittenger C., and Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33 1 (2008) 88-109
35. Plotsky P.M., Owens M.J., and Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21 2 (1998) 293-307
36. Provencher S.W. Estimation of metabolite concentrations fro localized in vivo proton NMR spectra. Magn. Reson. Med. 2 (1993) 201-208
37. Rajkowska G. Cell pathology in mood disorders. Semin. Clin. Neuropsychiatry 7 4 (2002) 281-292
38. Rosenberg D.R., Macmaster F.P., Mirza Y., Smith J.M., Easter P.C., Banerjee S.P., Bhandari R., Boyd C., Lynch M., Rose M., Ivey J., Villafuerte R.A., Moore G.J., and Renshaw P. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol. Psychiatry 58 9 (2005) 700-704
39. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol. Psychiatry 48 8 (2000) 755-765
40. Schuff N., Neylan T.C., Fox-Bosetti S., Lenoci M., Samuelson K.W., Studholme C., Kornak J., Marmar C.R., and Weiner M.W. Abnormal N acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Research: Neuroimaging 162 (2008) 147-157
41. Stanley J.A. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can. J. Psychiatry 47 4 (2002) 315-326
42. Taylor M., Murphy S.E., Selvaraj S., Wylezinkska M., Jezzard P., Cowen P.J., and Evans J. Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy. J. Psychopharm. 22 5 (2008) 473-476
43. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13 3 (1993) 981-989
44. Videbech P., and Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry, 161 11 (2004) 1957-1966
45. Wolfson M., Bersudsky Y., Hertz E., Berkin V., Zinger E., and Hertz L. A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition. Neurochem. Res. 25 7 (2000) 977-982
46. Young E., and Korszun A. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-gonadal axis. Psychiatr. Clin. North Am. 21 2 (1998) 309-323
47. Yucel K., Taylor V.H., McKinnon M.C., Macdonald K., Alda M., Young L.T., et al. Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment. Neuropsychopharmacology 33 2 (2008) 361-367